======= DYNC1I1 =======
== Gene Information ==
* **Official Symbol**: DYNC1I1
* **Official Name**: dynein cytoplasmic 1 intermediate chain 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1780|1780]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O14576|O14576]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DYNC1I1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DYNC1I1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603772|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. The intermediate chains mediate the binding of dynein to dynactin via its 150 kDa component (p150- glued) DCNT1. May play a role in mediating the interaction of cytoplasmic dynein with membranous organelles and kinetochores.
|Dynein IC2|
|WD40|
|dynein heavy chain binding|
|cytoplasmic dynein complex|
|dynein light chain binding|
|ATP-dependent microtubule motor activity, plus-end-directed|
|spectrin binding|
|vesicle transport along microtubule|
|motor activity|
|vesicle cytoskeletal trafficking|
|microtubule motor activity|
|cytoplasmic ribonucleoprotein granule|
|organelle transport along microtubule|
|kinetochore|
|condensed chromosome kinetochore|
|antigen processing and presentation of exogenous peptide antigen via MHC class II|
|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|
|antigen processing and presentation of peptide antigen via MHC class II|
|recycling endosome|
|spindle pole|
|vesicle|
|transport along microtubule|
|establishment of vesicle localization|
|cytoskeleton-dependent intracellular transport|
|antigen processing and presentation of exogenous peptide antigen|
|microtubule-based transport|
|antigen processing and presentation of exogenous antigen|
|vesicle localization|
|antigen processing and presentation of peptide antigen|
|endoplasmic reticulum to Golgi vesicle-mediated transport|
|antigen processing and presentation|
|microtubule binding|
|microtubule-based movement|
|microtubule|
|establishment of organelle localization|
|Golgi vesicle transport|
|organelle localization|
|microtubule-based process|
|perinuclear region of cytoplasm|
|intracellular transport|
|movement of cell or subcellular component|
|establishment of localization in cell|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.83|
|[[:results:exp496|Lead acetate 990μM R08 exp496]]|-1.75|
|[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|1.76|
|[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.91|
|[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|2.12|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15572
* **Expression level (log2 read counts)**: -0.46
{{:chemogenomics:nalm6 dist.png?nolink |}}